Document is current
Any future updates will be listed below
-
Authors
Custode, Bruno Maria
Annunziata, Francesco
Dos Santos Matos, Felipe
Schiano, Valentina
Maffia, Veronica
Lillo, Milena
Colonna, Rita
De Cegli, Rossella https://orcid.org/0000-0002-8526-8692
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
Pastore, Nunzia https://orcid.org/0000-0002-8701-5592
- License Information
-
More Information
Article History
Received: 28 August 2024
Revised: 11 February 2025
Accepted: 17 March 2025
First Online: 6 April 2025
Change Date: 2 May 2025
Change Type: Update
Change Details: The author has been mistakenly affiliated with affiliation 2. This has been corrected to affiliation 4.
Competing interests
: AB is cofounder and shareholder of CASMA Therapeutics, Inc, and Advisory board member of Avilar Therapeutics and Amplify Therapeutics.
: The manuscript reporting studies did not involve human participants, human data or human tissue. The animal experiments were accomplished in compliance with ethical standards. All experiments were approved by the Italian Ministry of Health with the approved number CE571.65 and were performed in accordance with the legal mandates and federal guidelines for the care and maintenance of laboratory animals.
